查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1587457

腺結合病毒載體製造市場規模、佔有率、趨勢分析報告：2025-2030年按業務規模、方法、治療領域、應用、地區和細分市場預測

Adeno Associated Virus Vector Manufacturing Market Size, Share & Trends Analysis Report By Scale Of Operations (Clinical, Preclinical, Commercial), By Method, By Therapeutic Area, By Application, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 130 Pages | 商品交期: 2-10個工作天內

價格

腺結合病毒載體製造市場的成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計到2030年，全球腺結合病毒載體製造市場規模將達27.8億美元，2025年至2030年複合年成長率為18.55%。

這種成長是由於癌症、囊腫纖維化、Duchenne氏肌肉失養症和色素性視網膜炎等慢性疾病的盛行率不斷增加所致。腺結合病毒（AAV）載體在這些疾病的治療中發揮重要作用。 AAV 載體也廣泛應用於基因治療傳遞。每家公司都致力於聯合研究、合併和聯盟，隨著研發的進展將創新產品推向市場。

例如，2021年12月， Astellas Pharma 和 Dyno Therapeutics 達成策略合作，利用 Dyno 的 CapsidMap 平台開發基於 NGS 的 AAV 載體，用於心臟和骨骼肌的基因治療。這些努力預計將擴大我們在抗體開發和生產市場的影響力，並有望支持市場成長。 COVID-19 大流行對該行業產生了積極影響。由於腺結合病毒在疫苗生產中具有廣泛的應用，因此多家公司已加入生產治療 COVID-19 疫苗的競賽。結果，製造這些載體的需求激增。

例如，2021年9月，CEVEC與UCB簽署策略協議，使用ELEVECTA AAV載體製造技術進行研發與基因治療應用。由於基因治療涉及修改基因，因此存在許多倫理問題。因此，美國政府限制了聯邦資金用於種系基因治療研究的使用。基因療法可以幫助您家庭的後代避免患有某些遺傳疾病。然而，預計它會對胎兒發育產生重大影響。對疫苗、基因治療藥物、CGMP 藥物、治療和治愈急性疾病的產品的高需求以及對改善患者照護的需求也在推動行業成長。因此，全球相關人員正在進行大量投資以擴大產能，以滿足不斷成長的需求。

腺結合病毒載體製造市場報告亮點

  • 從業務規模來看，2024年商業領域將佔據產業主導地位。由於企業加大研發投入以及疫苗生產商的需求。
  • 由於慢性神經退化性疾病的高盛行率以及腺結合病毒載體的療法治療這些疾病的功效，神經系統疾病治療領域在 2024 年佔據最大佔有率。
  • 疫苗被認為是一個主要應用領域，在 2024 年佔收益佔有率，並且由於對疫苗治療的需求不斷成長以及疫苗生產的投資和資金可能會持續增加，因此在整個預測期內將保持主導地位。
  • 北美已確立了強大的區域地位。隨著該地區的公司開發產品，癌症發病率的上升和研發成本的上升正在推動該地區的市場。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章 市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場趨勢及展望
    • 市場動態
    • 市場限制因素分析
  • 營商環境分析
    • SWOT 分析；按因素（政治/法律、經濟/技術）
    • 波特五力分析
    • COVID-19 影響分析

第4章 業務規模分析

  • 企業規模細分儀表板
  • 全球腺結合病毒載體製造市場：業務規模波動分析
  • 2018-2030年全球腺結合病毒載體製造市場規模及趨勢分析（依業務規模）
  • 臨床
    • 臨床市場，2018-2030
  • 臨床前
    • 臨床前市場，2018-2030
  • 商業的
    • 商業市場，2018-2030

第5章業務分析方法

  • 方法細分儀表板
  • 全球腺結合病毒載體製造市場：方法變異分析
  • 2018-2030年全球腺結合病毒載體製造市場規模及趨勢分析（依方法）
  • In Vitro
    • 體外市場，2018-2030
  • In Vivo
    • 體內市場，2018-2030

第6章 治療領域業務分析

  • 治療區域細分儀表板
  • 全球腺結合病毒載體生產市場：治療領域波動分析
  • 2018-2030年全球腺結合病毒載體製造市場規模及趨勢分析（依治療領域）
  • 血液疾病
    • 血液疾病市場，2018-2030
  • 感染疾病
    • 感染疾病市場，2018-2030
  • 遺傳疾病
    • 遺傳疾病市場，2018-2030
  • 神經系統疾病
    • 神經系統疾病市場，2018-2030
  • 眼科疾病
    • 2018-2030年眼科疾病市場
  • 其他
    • 其他市場，2018-2030

第7章 應用業務分析

  • 使用細分儀表板
  • 全球腺結合病毒載體製造市場：應用變異分析
  • 2018-2030年全球腺結合病毒載體製造市場規模及趨勢分析（按應用）
  • 細胞療法
    • 細胞治療市場，2018-2030
  • 基因治療
    • 基因治療市場，2018-2030
  • 疫苗
    • 疫苗市場，2018-2030

第8章區域業務分析

  • 區域儀表板
  • 2018-2030年市場規模及預測及趨勢分析
  • 北美洲
    • 北美腺結合病毒載體製造市場，2018-2030
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2018-2030年歐洲腺結合病毒載體製造市場
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 亞太地區腺結合病毒載體製造市場，2018-2030
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 拉丁美洲腺結合病毒載體製造市場，2018-2030
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 2018-2030年中東及非洲腺結合病毒載體製造市場
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭格局

  • 參與企業
  • 策略規劃
  • 2024 年企業市場分析
  • 參與企業概況
    • F. Hoffmann-La Roche Ltd
    • Charles River Laboratories
    • Oxford Biomedica PLC
    • WuXi AppTec
    • Yposkesi, Inc.
    • Sarepta Therapeutics, Inc.
    • Pfizer Inc.
    • Genezen
    • Creative Biogene
    • GenScript（ProBio）
Product Code: GVR-4-68040-037-5

Adeno Associated Virus Vector Manufacturing Market Growth & Trends:

The global adeno associated virus vector manufacturing market size is expected to reach USD 2.78 billion by 2030, registering a CAGR of 18.55% from 2025 to 2030, according to a new report by Grand View Research, Inc. This growth is attributed to the increasing prevalence of chronic diseases like cancers, cystic fibrosis, Duchenne muscular dystrophy, retinitis pigmentosa, and many more. Adeno-associated virus (AAV) vector plays a vital role in the treatment of these diseases. AAV vectors also have a wide range of applications in gene therapy delivery. Companies are engaged in collaborations, mergers, and partnerships for innovative product launches with advancements in R&D.

For instance, in December 2021, Astellas and Dyno Therapeutics entered into a strategic collaboration to develop an NGS-based AAV vector for gene therapy by using Dyno's CapsidMap platform for cardiac and skeletal muscle. Such initiatives are expected to expand their market presence in the development and production of antibodies, which is likely to support the growth of the market. The COVID-19 pandemic had a positive impact on the industry. As adeno associated virus has vast applications in vaccine manufacturing, various companies were involved in the race to manufacture the vaccine to treat COVID-19. This resulted in a sudden spur in the demand for manufacturing these vectors.

For instance, in September 2021, CEVEC and UCB entered into a strategic agreement for the use of ELEVECTA AAV vector manufacturing technology for R&D and gene therapy applications. As gene therapy involves alterations or modifications in the set of genes, it has raised many ethical issues. As a result, the U.S. government restricted the usage of federal funds for research on germline gene therapy in people. Gene therapy can help save future generations of a family from acquiring a particular genetic disorder. However, it is anticipated to affect the fetus's development significantly. The high demand for vaccines, gene therapeutics, CGMP drugs, and products to treat & cure acute diseases and the demand for improving patient care also propel the industry growth. Thus, global stakeholders are investing significantly in expanding their production capacities to fulfill the growing demands.

Adeno Associated Virus Vector Manufacturing Market Report Highlights:

  • By the scale of operations, the commercial segment dominated the industry in 2024. Owing to the increasing R&D investment by companies and demand from vaccine manufacturers
  • The neurological diseases therapeutic area segment captured the largest share in 2024 due to the high prevalence of chronic neurodegenerative diseases and the effectiveness of the adeno associated virus vector-based therapies to treat these diseases
  • Vaccine is considered a key application segment, which held the largest revenue share in 2024 and is likely to remain dominant throughout the forecast period due to the rising demand for vaccine therapeutics and increasing investments & funds for the production of vaccines
  • North America has established a strong regional position. The increasing incidence of cancer and high R&D expenditure is encouraging companies in the region to undertake product development, which drives the regional market

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Scale of Operations
    • 1.2.2. Method
    • 1.2.3. Therapeutic Area
    • 1.2.4. Application
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
    • 3.2.1. Market Dynamics
      • 3.2.1.1. Technological advancements in manufacturing vectors
      • 3.2.1.2. Robust pipelines for gene therapies and vaccines
      • 3.2.1.3. Increasing number of emerging players
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Regulatory, scientific and ethical challenges
      • 3.2.2.2. Production capacity challenges
  • 3.3. Business Environment Analysis
    • 3.3.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.3.2. Porter's Five Forces Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Scale Of Operations Business Analysis

  • 4.1. Scale of Operations Segment Dashboard
  • 4.2. Global Adeno Associated Virus Vector Manufacturing Market: Scale of Operations Movement Analysis
  • 4.3. Global Adeno Associated Virus Vector Manufacturing Market Size & Trend Analysis, by Scale of Operations, 2018 to 2030 (USD Million)
  • 4.4. Clinical
    • 4.4.1. Clinical Market, 2018 - 2030 (USD Million)
  • 4.5. Preclinical
    • 4.5.1. Preclinical Market, 2018 - 2030 (USD Million)
  • 4.6. Commercial
    • 4.6.1. Commercial Market, 2018 - 2030 (USD Million)

Chapter 5. Method Business Analysis

  • 5.1. Method Segment Dashboard
  • 5.2. Global Adeno Associated Virus Vector Manufacturing Market: Method Movement Analysis
  • 5.3. Global Adeno Associated Virus Vector Manufacturing Market Size & Trend Analysis, by Method, 2018 to 2030 (USD Million)
  • 5.4. In Vitro
    • 5.4.1. In Vitro Market, 2018 - 2030 (USD Million)
  • 5.5. In Vivo
    • 5.5.1. In Vivo Market, 2018 - 2030 (USD Million)

Chapter 6. Therapeutic Area Business Analysis

  • 6.1. Therapeutic Area Segment Dashboard
  • 6.2. Global Adeno Associated Virus Vector Manufacturing Market: Therapeutic Area Movement Analysis
  • 6.3. Global Adeno Associated Virus Vector Manufacturing Market Size & Trend Analysis, by Therapeutic Area, 2018 to 2030 (USD Million)
  • 6.4. Hematological Diseases
    • 6.4.1. Hematological Diseases Market, 2018 - 2030 (USD Million)
  • 6.5. Infectious Diseases
    • 6.5.1. Infectious Diseases Market, 2018 - 2030 (USD Million)
  • 6.6. Genetic Disorders
    • 6.6.1. Genetic Disorders Market, 2018 - 2030 (USD Million)
  • 6.7. Neurological Disorders
    • 6.7.1. Neurological Disorders Market, 2018 - 2030 (USD Million)
  • 6.8. Ophthalmic Disorders
    • 6.8.1. Ophthalmic Disorders Market, 2018 - 2030 (USD Million)
  • 6.9. Others
    • 6.9.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Application Business Analysis

  • 7.1. Application Segment Dashboard
  • 7.2. Global Adeno Associated Virus Vector Manufacturing Market: Application Movement Analysis
  • 7.3. Global Adeno Associated Virus Vector Manufacturing Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 7.4. Cell Therapy
    • 7.4.1. Cell Therapy Market, 2018 - 2030 (USD Million)
  • 7.5. Gene Therapy
    • 7.5.1. Gene Therapy Market, 2018 - 2030 (USD Million)
  • 7.6. Vaccine
    • 7.6.1. Vaccine Market, 2018 - 2030 (USD Million)

Chapter 8. Regional Business Analysis

  • 8.1. Regional Dashboard
  • 8.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 8.3. North America
    • 8.3.1. North America Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Target Disease Prevalence
      • 8.3.2.3. Competitive Scenario
      • 8.3.2.4. Regulatory Framework
      • 8.3.2.5. U.S. Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Target Disease Prevalence
      • 8.3.3.3. Competitive Scenario
      • 8.3.3.4. Regulatory Framework
      • 8.3.3.5. Canada Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Target Disease Prevalence
      • 8.3.4.3. Competitive Scenario
      • 8.3.4.4. Regulatory Framework
      • 8.3.4.5. Mexico Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.4.2. Germany
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Target Disease Prevalence
      • 8.4.2.3. Competitive Scenario
      • 8.4.2.4. Regulatory Framework
      • 8.4.2.5. Germany Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.4.3. UK
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Target Disease Prevalence
      • 8.4.3.3. Competitive Scenario
      • 8.4.3.4. Regulatory Framework
      • 8.4.3.5. UK Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Target Disease Prevalence
      • 8.4.4.3. Competitive Scenario
      • 8.4.4.4. Regulatory Framework
      • 8.4.4.5. France Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Target Disease Prevalence
      • 8.4.5.3. Competitive Scenario
      • 8.4.5.4. Regulatory Framework
      • 8.4.5.5. Italy Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Target Disease Prevalence
      • 8.4.6.3. Competitive Scenario
      • 8.4.6.4. Regulatory Framework
      • 8.4.6.5. Spain Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.4.7. Denmark
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Target Disease Prevalence
      • 8.4.7.3. Competitive Scenario
      • 8.4.7.4. Regulatory Framework
      • 8.4.7.5. Denmark Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.4.8. Sweden
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Target Disease Prevalence
      • 8.4.8.3. Competitive Scenario
      • 8.4.8.4. Regulatory Framework
      • 8.4.8.5. Sweden Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Target Disease Prevalence
      • 8.4.9.3. Competitive Scenario
      • 8.4.9.4. Regulatory Framework
      • 8.4.9.5. Norway Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Target Disease Prevalence
      • 8.5.2.3. Competitive Scenario
      • 8.5.2.4. Regulatory Framework
      • 8.5.2.5. Japan Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Target Disease Prevalence
      • 8.5.3.3. Competitive Scenario
      • 8.5.3.4. Regulatory Framework
      • 8.5.3.5. China Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Target Disease Prevalence
      • 8.5.4.3. Competitive Scenario
      • 8.5.4.4. Regulatory Framework
      • 8.5.4.5. India Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Target Disease Prevalence
      • 8.5.5.3. Competitive Scenario
      • 8.5.5.4. Regulatory Framework
      • 8.5.5.5. South Korea Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.5.6. Australia
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Target Disease Prevalence
      • 8.5.6.3. Competitive Scenario
      • 8.5.6.4. Regulatory Framework
      • 8.5.6.5. Australia Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.5.7. Thailand
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Target Disease Prevalence
      • 8.5.7.3. Competitive Scenario
      • 8.5.7.4. Regulatory Framework
      • 8.5.7.5. Thailand Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Target Disease Prevalence
      • 8.6.2.3. Competitive Scenario
      • 8.6.2.4. Regulatory Framework
      • 8.6.2.5. Brazil Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Target Disease Prevalence
      • 8.6.3.3. Competitive Scenario
      • 8.6.3.4. Regulatory Framework
      • 8.6.3.5. Argentina Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
  • 8.7. MEA
    • 8.7.1. MEA Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Target Disease Prevalence
      • 8.7.2.3. Competitive Scenario
      • 8.7.2.4. Regulatory Framework
      • 8.7.2.5. South Africa Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.7.3. Saudi Arabia
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Target Disease Prevalence
      • 8.7.3.3. Competitive Scenario
      • 8.7.3.4. Regulatory Framework
      • 8.7.3.5. Saudi Arabia Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Target Disease Prevalence
      • 8.7.4.3. Competitive Scenario
      • 8.7.4.4. Regulatory Framework
      • 8.7.4.5. UAE Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Target Disease Prevalence
      • 8.7.5.3. Competitive Scenario
      • 8.7.5.4. Regulatory Framework
      • 8.7.5.5. Kuwait Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Participant Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2024
  • 9.4. Participant's Overview
    • 9.4.1. F. Hoffmann-La Roche Ltd
      • 9.4.1.1. Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Service Benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. Charles River Laboratories
      • 9.4.2.1. Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Service Benchmarking
      • 9.4.2.4. Strategic Initiatives
    • 9.4.3. Oxford Biomedica PLC
      • 9.4.3.1. Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Service Benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. WuXi AppTec
      • 9.4.4.1. Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Service Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. Yposkesi, Inc.
      • 9.4.5.1. Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Service Benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. Sarepta Therapeutics, Inc.
      • 9.4.6.1. Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Service Benchmarking
      • 9.4.6.4. Strategic Initiatives
    • 9.4.7. Pfizer Inc.
      • 9.4.7.1. Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Service Benchmarking
      • 9.4.7.4. Strategic Initiatives
    • 9.4.8. Genezen
      • 9.4.8.1. Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Service Benchmarking
      • 9.4.8.4. Strategic Initiatives
    • 9.4.9. Creative Biogene
      • 9.4.9.1. Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Service Benchmarking
      • 9.4.9.4. Strategic Initiatives
    • 9.4.10. GenScript (ProBio)
      • 9.4.10.1. Overview
      • 9.4.10.2. Financial Performance
      • 9.4.10.3. Service Benchmarking
      • 9.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 Global adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 3 Global adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 4 Global adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 5 Global adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 6 Global adeno associated virus vector manufacturing market, by region, 2018 - 2030 (USD Million)
  • Table 7 North America adeno associated virus vector manufacturing market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 9 North America adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 10 North America adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 11 North America adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 12 U.S. adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 13 U.S. adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 14 U.S. adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 15 U.S. adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 16 Canada adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 17 Canada adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 18 Canada adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 19 Canada adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 20 Mexico adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 21 Mexico adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 22 Mexico adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 23 Mexico adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 24 Europe adeno associated virus vector manufacturing market, by country, 2018 - 2030 (USD Million)
  • Table 25 Europe adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 26 Europe adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 27 Europe adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 28 Europe adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 29 UK adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 30 Europe adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 31 UK adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 32 UK adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 33 Germany adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 34 Germany adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 35 Germany adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 36 Germany adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 37 France adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 38 France adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 39 France adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 40 France adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 41 Italy adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 42 Italy adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 43 Italy adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 44 Italy adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 45 Spain adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 46 Spain adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 47 Spain adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 48 Spain adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 49 Denmark adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 50 Denmark adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 51 Denmark adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 52 Denmark adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 53 Sweden adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 54 Sweden adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 55 Sweden adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 56 Sweden adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 57 Norway adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 58 Norway adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 59 Norway adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 60 Norway adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific adeno associated virus vector manufacturing market, by country, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 66 Japan adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 67 Japan adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 68 Japan adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 69 Japan adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 70 China adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 71 China adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 72 China adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 73 China adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 74 India adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 75 India adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 76 India adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 77 India adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 78 Australia adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 79 Australia adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 80 Australia adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 81 Australia adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 82 Thailand adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 83 Thailand adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 84 Thailand adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 85 Thailand adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 86 South Korea adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 87 South Korea adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 88 South Korea adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 89 South Korea adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 90 Latin America adeno associated virus vector manufacturing market, by country, 2018 - 2030 (USD Million)
  • Table 91 Latin America adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 92 Latin America adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 93 Latin America adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 94 Latin America adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 95 Brazil adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 96 Brazil adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 97 Brazil adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 98 Brazil adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 99 Argentina adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 100 Argentina adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 101 Argentina adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 102 Argentina adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 103 Middle East and Africa adeno associated virus vector manufacturing market, by country, 2018 - 2030 (USD Million)
  • Table 104 Middle East and Africa adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 105 Middle East and Africa adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 106 Middle East and Africa adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 107 Middle East and Africa adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 108 South Africa adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 109 South Africa adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 110 South Africa adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 111 South Africa adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 112 Saudi Arabia adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 116 UAE adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 117 UAE adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 118 UAE adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 119 UAE adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 120 Kuwait adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 121 Kuwait adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 122 Kuwait adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 123 Kuwait adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Adeno associated virus vector manufacturing market segmentation
  • Fig. 8 Market snapshot
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 Market challenge relevance analysis (current & future impact)
  • Fig. 13 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 Global adeno associated virus vector manufacturing market: mode movement analysis
  • Fig. 16 Global adeno associated virus vector manufacturing market, for in vitro, 2018 - 2030 (USD Million)
  • Fig. 17 Global adeno associated virus vector manufacturing market, for in vivo, 2018 - 2030 (USD Million)
  • Fig. 18 Global adeno associated virus vector manufacturing market: scale of operations movement analysis
  • Fig. 19 Global adeno associated virus vector manufacturing market, for clinical, 2018 - 2030 (USD Million)
  • Fig. 20 Global adeno associated virus vector manufacturing market, for preclinical, 2018 - 2030 (USD Million)
  • Fig. 21 Global adeno associated virus vector manufacturing market, for commercial, 2018 - 2030 (USD Million)
  • Fig. 22 Global adeno associated virus vector manufacturing market: therapeutic area movement analysis
  • Fig. 23 Global adeno associated virus vector manufacturing market, for haematological diseases, 2018 - 2030 (USD Million)
  • Fig. 24 Global adeno associated virus vector manufacturing market, for infectious diseases, 2018 - 2030 (USD Million)
  • Fig. 25 Global adeno associated virus vector manufacturing market, for genetic disorders, 2018 - 2030 (USD Million)
  • Fig. 26 Global adeno associated virus vector manufacturing market, for neurological disorders, 2018 - 2030 (USD Million)
  • Fig. 27 Global adeno associated virus vector manufacturing market, for ophthalmic disorders, 2018 - 2030 (USD Million)
  • Fig. 28 Global adeno associated virus vector manufacturing market, for others, 2018 - 2030 (USD Million)
  • Fig. 29 Global adeno associated virus vector manufacturing market: application movement analysis
  • Fig. 30 Global adeno associated virus vector manufacturing market, for cell therapy, 2018 - 2030 (USD Million)
  • Fig. 31 Global adeno associated virus vector manufacturing market, for gene therapy, 2018 - 2030 (USD Million)
  • Fig. 32 Global adeno associated virus vector manufacturing market, for vaccine, 2018 - 2030 (USD Million)
  • Fig. 33 Regional marketplace: Key takeaways
  • Fig. 34 Regional outlook, 2024 & 2030
  • Fig. 35 Global adeno associated virus vector manufacturing market: region movement analysis
  • Fig. 36 North America adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 37 U.S. Adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 38 Canada adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 39 Mexico adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 40 Europe adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 41 Germany adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 42 UK adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 43 France adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 44 Italy adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 45 Spain adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 46 Denmark adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 47 Sweden adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 48 Norway adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 49 Asia pacific adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 50 Japan adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 51 China adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 52 India adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 53 Australia adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 54 South Korea adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 55 Thailand adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 56 Latin America adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 57 Brazil adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 58 Argentina adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 59 Middle East and Africa adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 60 South Africa adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 61 Saudi Arabia adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 62 UAE adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 63 Kuwait adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)